These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4730980)

  • 1. [Treatment with pyrazinamide given in increased doses twice a week in combination with other drugs].
    Pregowski W; Stańczuk-Holub A
    Gruzlica; 1973 Jul; 41(7):795-802. PubMed ID: 4730980
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and laboratory studies in patients with pulmonary tuberculosis treated with pyrazinamide].
    Savula MM; Smolenko MI; Romaniuk MD; Slivka IuI
    Probl Tuberk; 1990; (11):25-8. PubMed ID: 2290809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short course chemotherapy for pulmonary tuberculosis. 3. Initial intensive regimens including pyrazinamide].
    Suzuki T; Shimada M; Yamaguchi W; Kameda K; Okamura S; Aizawa H
    Kekkaku; 1983 Sep; 58(9):459-64. PubMed ID: 6663962
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 6. [Kidney function in patients with pulmonary tuberculosis during treatment with antitubercular agents, with special reference to pyrazinamide].
    Spychalski W; Grzegorzewska A; Westfal I
    Pneumonol Pol; 1987 Oct; 55(10):454-7. PubMed ID: 3438179
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-term chemotherapy of tuberculosis with 5-month regimens with and without pyrazinamide in the 2d phase (TA-82)].
    Farga V; Valenzuela P; Valenzuela MT; Schell G; Lagos A; Nuñez A; Soto R; Fernández M; Corradini ; Araya D
    Rev Med Chil; 1986 Jul; 114(7):701-5. PubMed ID: 3299595
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C; Cornia G; Cirianni C; Garimoldi M; Ginesu F; Mandler F; Perna G; Pradella F
    G Ital Chemioter; 1968; 15(4):92-4. PubMed ID: 5744843
    [No Abstract]   [Full Text] [Related]  

  • 10. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 11. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intermittent method of treatment of patients with pulmonary tuberculosis showing poor tolerance of antitubercular agents].
    Sushkin AG
    Vrach Delo; 1973 Nov; 11():94-7. PubMed ID: 4786944
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of 2 or 3 secondary drug combinations in the retreatment of chronic pulmonary tuberculosis].
    De March Ayuela P; Turell Gumá J
    Rev Clin Esp; 1968 Apr; 109(2):117-26. PubMed ID: 4904020
    [No Abstract]   [Full Text] [Related]  

  • 14. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST; Denkin SM; Zhang Y
    J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of the effect of morphazinamide and pyrazinamide in the treatment of chronic tuberculosis].
    Zierski M
    Gruzlica; 1965 Sep; 33(9):769-71. PubMed ID: 5859903
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of vitamin D on efficacy of pyrazinamide in pulmonary tuberculosis.
    Narang NK; Meratwal S; Jain D
    J Assoc Physicians India; 1991 May; 39(5):425-6. PubMed ID: 1960170
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
    Harries AD; Gausi F; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):724-9. PubMed ID: 15182142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.